Suchitra S. Acharya

TL;DR: Prevention of joint arthropathy needs to focus on prevention of haemarthroses through prophylaxis, identifying early joint disease through the optimal use of cost effective imaging modalities and the validation of serological markers of jointArthropathy.

TL;DR: In this paper, the early and midterm outcomes of multisystem inflammatory syndrome in children (MIS-C) were evaluated using a longitudinal 6-month cohort study of all children admitted and treated for MIS-C from April 17 to June 20, 2020.

TL;DR: Primary care and other nonhematologist pediatric providers should be familiar with the clinical presentation and initial evaluation of the rare bleeding disorders, as they often manifest during childhood and may present with recurrent or even serious or life-threatening bleeding episodes, particularly during the neonatal period.

TL;DR: Novel no-replacement strategies promoting hemostasis by through different mechanisms need to be studied in RBDs as alternative therapeutic options.

TL;DR: The experience in children infected with SARS‐CoV‐2 is reported, with noted elevations in D‐dimer and MCF on ROTEM (indicating hypercoagulability), and exploration of viscoelastic testing to provide additional laboratory‐based evidence for pediatric‐specific risk assessment for thromboprophylaxis in SARS' coagulopathy is warranted.